Caris Life Sciences Stock Total Asset
| CAI Stock | USD 28.38 1.97 7.46% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Caris Life's long-term financial health and intrinsic value.
| Last Reported | Projected for Next Year | ||
| Total Assets | 395.3 M | 375.5 M | |
| Intangibles To Total Assets | 0.06 | 0.04 |
Caris | Total Asset | Build AI portfolio with Caris Stock |
Caris Life Sciences Company Total Asset Analysis
Caris Life's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Caris Life Total Asset | 343.73 M |
Most of Caris Life's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Caris Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Caris Total Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Caris Life is extremely important. It helps to project a fair market value of Caris Stock properly, considering its historical fundamentals such as Total Asset. Since Caris Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Caris Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Caris Life's interrelated accounts and indicators.
Click cells to compare fundamentals
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Caris Total Assets
Total Assets |
|
Based on the latest financial disclosure, Caris Life Sciences has a Total Asset of 343.73 M. This is 91.42% lower than that of the Trading Companies & Distributors sector and 95.42% lower than that of the Industrials industry. The total asset for all United States stocks is 98.83% higher than that of the company.
Caris Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Caris Life's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Caris Life could also be used in its relative valuation, which is a method of valuing Caris Life by comparing valuation metrics of similar companies.Caris Life is currently under evaluation in total asset category among its peers.
Caris Life ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Caris Life's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Caris Life's managers, analysts, and investors.Environmental | Governance | Social |
Caris Fundamentals
| Profit Margin | (0.60) % | ||||
| Operating Margin | (0.48) % | ||||
| Current Valuation | 8.33 B | ||||
| Shares Outstanding | 283.56 M | ||||
| Shares Owned By Insiders | 48.15 % | ||||
| Shares Owned By Institutions | 16.18 % | ||||
| Number Of Shares Shorted | 5.43 M | ||||
| Price To Earning | 17.74 X | ||||
| Price To Sales | 17.55 X | ||||
| Revenue | 412.26 M | ||||
| Gross Profit | 211.38 M | ||||
| EBITDA | (182.95 M) | ||||
| Net Income | (281.89 M) | ||||
| Cash And Equivalents | 38.81 M | ||||
| Cash Per Share | 2.26 X | ||||
| Total Debt | 424.26 M | ||||
| Debt To Equity | 2.41 % | ||||
| Current Ratio | 0.45 X | ||||
| Book Value Per Share | (18.45) X | ||||
| Cash Flow From Operations | (245.2 M) | ||||
| Earnings Per Share | (1.25) X | ||||
| Price To Earnings To Growth | 0.90 X | ||||
| Number Of Employees | 1.77 K | ||||
| Beta | 1.47 | ||||
| Market Capitalization | 7.94 B | ||||
| Total Asset | 343.73 M | ||||
| Retained Earnings | (2.47 B) | ||||
| Working Capital | 50.31 M | ||||
| Current Asset | 131.15 M | ||||
| Current Liabilities | 215.06 M | ||||
| Net Asset | 343.73 M | ||||
| Last Dividend Paid | 1.2 |
About Caris Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Caris Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Caris Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Caris Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Caris Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Caris Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Caris Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Caris Life Sciences Stock:Check out Caris Life Piotroski F Score and Caris Life Altman Z Score analysis. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Trading Companies & Distributors space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Caris Life. If investors know Caris will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Caris Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Caris Life Sciences is measured differently than its book value, which is the value of Caris that is recorded on the company's balance sheet. Investors also form their own opinion of Caris Life's value that differs from its market value or its book value, called intrinsic value, which is Caris Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Caris Life's market value can be influenced by many factors that don't directly affect Caris Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Caris Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Caris Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Caris Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.